21 Women Innovators shortlisted for the 2021 EU Prize for Women Innovators

Brussels, October 20th 2021
Summary
  • The European Innovation Council shortlisted 21 women entrepreneurs for the 2021 EU Prize for Women Innovators.
  • Three main prizes of €100,000 each are available in the Women Innovators category and a Rising Innovator award of €50,000 recognises talent under 30.
  • Finalists cover a broad range of deep tech and applied innovations from medical diagnostics to AI, agrifood platforms, exoskeletons and sustainable biomass processing.
  • The prize is intended to raise visibility for women founders but structural funding and scaling barriers for female-led ventures remain significant.

21 finalists announced for the EU Prize for Women Innovators 2021

The European Innovation Council and the Executive Agency for Small and Medium-sized Enterprises (EISMEA) named 21 female entrepreneurs to the shortlist for the 2021 EU Prize for Women Innovators. The competition is funded under the EU research and innovation programme and aims to recognise women who have founded companies and brought disruptive innovations to market. The shortlist spans medtech, diagnostics, life sciences, sustainable chemistry, AI platforms, consumer-facing digital services and social inclusion technologies.

Seventeen candidates compete for three Women Innovators prizes of €100,000 each. A separate Rising Innovator award recognises promising female entrepreneurs under 30 with a €50,000 prize. The winners were due to be announced at the European Innovation Council Summit scheduled for 24–25 November 2021.

Mariya Gabriel, EU Commissioner for Innovation, Research, Culture, Education and Youth, commented: “Today, we celebrate the outstanding achievements of 21 women innovators. This exceptional group of women are making a significant contribution in their fields, and tackling society’s biggest challenges. By telling their story, we hope to inspire other women to engage with and realise their potential as future innovators.”

Finalists — Women Innovators category

NameCountryRoleCompanySector / One-line description
Anita FinneganIrelandCo-founder & CEONova LeahCybersecurity risk management solutions for medical device manufacturers
Asude AltıntaşTürkiyeCo-founder & CEOTwin ScienceSTEAM education for children using physical and digital products
Ciara ClancyIrelandFounder & CEOBeats TherapeuticsTechnology to address mobility symptoms in Parkinson’s disease
Danaë DelbekeBelgiumFounder & CEOIndigoInnovative glucose monitoring solutions for people with diabetes
Daphne Haim LangfordIsraelFounder & CEOTarsier PharmaTherapies for autoimmune and inflammatory ocular diseases
Elena García ArmadaSpainFounder & CEOMarsiBionicsPersonalised exoskeletons for gait therapy
Florence GschwendSwitzerland / UKCo-founder & CTOLixeaSustainable biomass fractionation using low-cost ionic liquids
Keren LeshemIsraelCo-founder & CEOOCON HealthcareIntrauterine drug-delivery technology to improve women’s health
Lisa O’DonoghueIrelandFounder & CEOVotechnikAutomated recycling technology for disposal of LCD units
Mathilde JakobsenDenmarkCo-founder & CEOFresh.LandDigital platform to shorten and digitise the food supply chain
Merel BoersNetherlandsCo-founder & CEONICO-LABTechnology to help physicians improve emergency care
Monika HaiderAustriaFounder & CEOequalizentEducation and training solutions for deaf and hard of hearing people
Patricia ScanlonIrelandFounder & Executive ChairSoapbox LabsSpeech-recognition solutions designed for children
Rocío ArroyoSpainFounder & CEOAMADIXPersonalised medicine solutions for cancer diagnosis
Sofie Quidenus-WahlforssAustria / GermanyFounder & CEOomni:usAI platform to automate insurance claims
Suzanne MoloneyIrelandFounder & CEOHidramed SolutionsAdvanced wound care solutions for chronic wounds
Verónica OrvalhoArgentina / PortugalFounder & CEODidimoPlatform for rapid creation of user-generated digital humans

Finalists — Rising Innovator category (under 30)

FoundersCountryCompanyProduct / Focus
Ailbhe and Izzy KeaneIrelandIzzy WheelsFashionable designer wheel covers for wheelchairs
Emna EverardBelgiumKazidomiE-commerce platform for healthy food
Livia NgUnited KingdomNeucruitDeep tech for digital patient recruitment to improve clinical trials

Prizes, organisers and selection process

The Women Innovators category offered three prizes of €100,000 each. The Rising Innovator prize carries €50,000. The competition is funded from EU research and innovation programmes and administered by the European Innovation Council and SMEs Executive Agency (EISMEA). Entries were open to women founders from EU Member States and countries associated to Horizon Europe. Winners are selected by an independent expert jury.

The EU Prize for Women Innovators dates from 2011 and is intended to raise awareness about the gender gap in entrepreneurship, provide role models and spotlight successful female founders. The award is primarily a recognition mechanism rather than a long-term funding instrument.

Context: why the prize still matters and its limits

The European Commission frames the prize within a larger push to increase gender equality in innovation ecosystems. The 2021 announcement reiterated persistent imbalances: the majority of European start‑ups are still founded by men and mixed or all‑women founding teams receive disproportionately small shares of venture capital. The Commission cited figures showing that three quarters of European start‑ups are founded by men and only 8 percent by all‑women teams. In 2019, 92 percent of VC funds raised by European VC‑backed companies went to all‑male founding teams.

Awards like this serve three functions: they create role models, signal institutional support and generate media visibility. However, visibility does not automatically translate into capital, procurement contracts or regulatory navigation support that are critical for scaling, in particular for deep tech and regulated medical ventures. Structural barriers such as biased investor networks, risk perception, and sector specific hurdles such as clinical validation and reimbursement remain key bottlenecks.

Horizon Europe and the EIC:Horizon Europe is the EU’s research and innovation funding programme. The European Innovation Council is an EU initiative within that framework to identify, support and scale breakthrough technologies and high‑potential SMEs. The EIC provides blended instruments including grants, equity investments, and business acceleration services. The SMEs Executive Agency (EISMEA) manages several EIC operational tasks such as prize administration and contract implementation.
What the prize does not solve:A cash prize and public recognition are helpful but insufficient to overcome systemic barriers. Women‑led companies commonly report tougher fundraising conditions, smaller deal sizes and sceptical investor responses. For deep tech and medtech firms, time to market is long and requires regulatory expertise, clinical evidence and procurement channels. These needs call for sustained follow‑on financing, access to trial sites, and public procurement that focuses on innovation demand.

Selected company and technology notes

A number of the shortlisted companies illustrate recurring themes and technical domains where Europe seeks competitive advantage. Below are short, contextual notes on a selection of finalists. These expand on the short descriptions in the official announcement and indicate the types of non‑financial support that often matter.

AMADIX — early cancer detection:AMADIX develops blood‑based diagnostics aimed at earlier detection of colorectal and other cancers. Early detection tests aim to combine molecular biomarkers with clinical data to improve sensitivity and specificity. For such companies, scaling requires extensive clinical validation, regulatory approvals and pathways into screening programmes or private diagnostics markets.
OCON Healthcare — intrauterine drug delivery:OCON is developing intrauterine devices that combine mechanical design with drug delivery to treat gynaecological conditions while reducing systemic side effects. Medical device companies face a demanding regulatory environment in Europe and elsewhere, including clinical trials and post‑market surveillance obligations under MDR or equivalent frameworks.
Lixea — biomass fractionation with ionic liquids:Lixea’s Dendronic process uses ionic liquid‑based chemistry to fractionate lignocellulosic biomass into cellulose and lignin streams suitable for higher value chemicals and materials. Technologies of this type target the circular bioeconomy but require demonstration at scale, solvent recycling optimisation and partnerships with downstream materials users to build demand.
Soapbox Labs — children's speech recognition:Speech recognition tuned to children’s voices requires specialised datasets and models because children’s speech patterns differ from adults. Soapbox Labs focuses on voice AI built from child speech samples and aims to provide privacy‑aware classroom tools. Adoption depends on accuracy, privacy guarantees and integration into educational workflows.
Nova Leah — cybersecurity for connected medical devices:As medical devices become networked, device cybersecurity has become a regulatory and safety priority. Nova Leah offers tooling for manufacturers and integrators to operationalise risk management across devices and supply chains. Cybersecurity scale‑up needs alignment with regulatory reporting, SBOM tracking and integration into quality management systems.
Izzy Wheels — inclusive design and consumerisation:Izzy Wheels markets fashionable wheel covers for wheelchairs to help users reject medicalised aesthetics and assert identity. Commercial success for consumer‑facing assistive products often depends on design, distribution channels, partnerships with health systems where relevant and advocacy to reach potential users.

What comes next and why follow‑on support matters

Prizes create a useful spotlight. But for the EU to convert role models into a sustained increase in women founders and women‑led scaleups, prizes need to be part of a broader package. That package should include targeted follow‑on funding, procurement pipelines that de‑risk adoption of novel solutions, regulatory and reimbursement navigation help for healthcare innovators, and investor‑matching that reduces information asymmetries for female founders.

Policy levers available to the European Commission and member state innovation agencies include Women‑focused acceleration programs, procurement set‑asides or innovation‑friendly tenders, VC incentive structures and more active use of public investment vehicles to co‑invest with private capital. The EIC already offers blended instruments that combine grants and equity; ensuring these instruments are accessible and visible to female founders could help address some capital gaps.

Practical takeaway for readers

If you are a woman founder, a potential investor, a procurement manager or a policy practitioner, the shortlist is a useful watchlist of European innovation that merits closer scrutiny. For funders and public bodies, the case for combining visibility prizes with practical scaling support is clear. For journalists and communicators, building sustained coverage that follows winners beyond the award moment will better reveal whether prizes translate into business impact.

Where to find more information

The winners were to be announced at the European Innovation Council Summit on 24–25 November 2021. The EIC and EISMEA publish programme details, prize rules and finalist information on their websites. For background on the EIC, consult the European Innovation Council pages under the European Commission and the EISMEA agency pages.